US Stock MarketDetailed Quotes

Dyne Therapeutics (DYN)

Watchlist
  • 17.920
  • -0.140-0.78%
Close Mar 13 15:59 ET
  • 17.990
  • +0.070+0.39%
Post 20:01 ET
2.96BMarket Cap-5.16P/E (TTM)

Dyne Therapeutics (DYN) Key Financial Indicators

DYN Earnings per Share (EPS)

According to the latest financial report of Dyne Therapeutics, the latest earnings per share (TTM) for the company is -0.76. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

DYN Free Cash Flow (FCF)

Interested in knowing about Dyne Therapeutics's free cash flow? The latest report shows it as -112.32M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

DYN Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Dyne Therapeutics shows that the company's current ratio is 22.25, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

DYN Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Dyne Therapeutics, the quick ratio is 21.94, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

DYN Return on Equity (ROE)

Want to learn more about the financial health of Dyne Therapeutics? The latest ROE figure is -13.46%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

DYN Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Dyne Therapeutics, the total asset return on investment (ROA) is -10.90%.

Currency: USD

Quarterly

Loading...

DYN Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Dyne Therapeutics's latest financial report to see how their gross margin is doing - currently at 28.87%.

Currency: USD

Quarterly

Loading...

DYN Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Dyne Therapeutics, the net profit margin is -9.56%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More